mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
3e-12 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-10 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
6e-10 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-07 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-07 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-07 |